X-group (possible homology)

303 Pyruvoyl-dependent histidine and arginine decarboxylases

Open in classification tree →

Ligands and drugs

131

Member domains

with ligand contacts (≤ 4 Å)

24.4% of members

with DrugDomain annotations

6.9% of members

with a DrugBank compound

2.3% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

Proteins with classified ligands

Superclasses bound (of 23)

—

Superclasses per 20 proteins

fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

Superclass	Proteins	Expected	Ratio	Significance
Organic nitrogen compounds	1	0.0	32×	not tested
Organic acids and derivatives	1	0.2	6.55×	not tested
Organic oxygen compounds	1	0.2	5.09×	not tested

enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBank	PDB ligand	Name	Domains
DB08838	AG2	Agmatine	3
DB00119	PYR	Pyruvic acid	1

Most frequently bound compounds

PDB ligand	Name	Domains in contact
AG2	AGMATINE	26
MRD	(4R)-2-METHYLPENTANE-2,4-DIOL	13
PYR	PYRUVIC ACID	4